| scholarly article | Q13442814 |
| P356 | DOI | 10.1021/BI061727O |
| P698 | PubMed publication ID | 17315983 |
| P2093 | author name string | Arnold E Ruoho | |
| Yuenmu Chen | |||
| Abdol R Hajipour | |||
| Marty Arbabian | |||
| Michael K Sievert | |||
| P433 | issue | 11 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 3532-3542 | |
| P577 | publication date | 2007-02-23 | |
| P1433 | published in | Biochemistry | Q764876 |
| P1476 | title | Characterization of the cocaine binding site on the sigma-1 receptor | |
| P478 | volume | 46 |
| Q47968720 | 3D Homology Model of Sigma1 Receptor |
| Q30400072 | A Review of the Human Sigma-1 Receptor Structure |
| Q39851539 | A novel photoaffinity ligand for the dopamine transporter based on pyrovalerone |
| Q34882628 | Accelerated retinal ganglion cell death in mice deficient in the Sigma-1 receptor |
| Q24626957 | An unambiguous assay for the cloned human sigma1 receptor reveals high affinity interactions with dopamine D4 receptor selective compounds and a distinct structure-affinity relationship for butyrophenones |
| Q34655500 | An update on the development of drugs for neuropsychiatric disorders: focusing on the sigma 1 receptor ligand |
| Q34153285 | Azido-iodo-N-benzyl derivatives of threo-methylphenidate (Ritalin, Concerta): Rational design, synthesis, pharmacological evaluation, and dopamine transporter photoaffinity labeling |
| Q35602646 | Characterization of interactions of 4-nitrophenylpropyl-N-alkylamine with ς receptors |
| Q30646785 | Characterization of the human sigma-1 receptor chaperone domain structure and binding immunoglobulin protein (BiP) interactions |
| Q35163209 | Cholesterol at the endoplasmic reticulum: roles of the sigma-1 receptor chaperone and implications thereof in human diseases |
| Q89032160 | Cocaine engages a non-canonical, dopamine-independent, mechanism that controls neuronal excitability in the nucleus accumbens |
| Q83227323 | Cocaine-induced endocannabinoid signaling mediated by sigma-1 receptors and extracellular vesicle secretion |
| Q37009426 | Drugs of abuse and human placenta |
| Q28506354 | Dynamic interaction between sigma-1 receptor and Kv1.2 shapes neuronal and behavioral responses to cocaine |
| Q34721365 | Effect of structural modification in the amine portion of substituted aminobutyl-benzamides as ligands for binding σ1 and σ2 receptors |
| Q39550739 | Electron-donating para-methoxy converts a benzamide-isoquinoline derivative into a highly Sigma-2 receptor selective ligand |
| Q42151070 | Improved expression and purification of sigma 1 receptor fused to maltose binding protein by alteration of linker sequence |
| Q38361893 | Intrinsic plasticity: an emerging player in addiction |
| Q39680665 | Juxtaposition of the steroid binding domain-like I and II regions constitutes a ligand binding site in the sigma-1 receptor |
| Q36099544 | Ligand-dependent localization and intracellular stability of sigma-1 receptors in CHO-K1 cells |
| Q90263450 | Neuronal Sigma-1 Receptors: Signaling Functions and Protective Roles in Neurodegenerative Diseases |
| Q37545379 | Pharmacology and therapeutic potential of sigma(1) receptor ligands |
| Q34549698 | Photoaffinity labeling of the sigma-1 receptor with N-[3-(4-nitrophenyl)propyl]-N-dodecylamine: evidence of receptor dimers |
| Q30369887 | Probing the steroid binding domain-like I (SBDLI) of the sigma-1 receptor binding site using N-substituted photoaffinity labels. |
| Q38235503 | Selective sigma-1 receptor antagonists for the treatment of pain. |
| Q101226279 | Sigma-1 receptor chaperones rescue nucleocytoplasmic transport deficit seen in cellular and Drosophila ALS/FTD models |
| Q37214692 | Steroid hormones affect binding of the sigma ligand 11C-SA4503 in tumour cells and tumour-bearing rats |
| Q36590723 | Synthesis and characterization of N,N-dialkyl and N-alkyl-N-aralkyl fenpropimorph-derived compounds as high affinity ligands for sigma receptors |
| Q34626137 | Targeting sigma-1 receptor signaling by endogenous ligands for cardioprotection |
| Q51750311 | The calcium-sensitive Sigma-1 receptor prevents cannabinoids from provoking glutamate NMDA receptor hypofunction: implications in antinociception and psychotic diseases. |
| Q24598801 | The hallucinogen N,N-dimethyltryptamine (DMT) is an endogenous sigma-1 receptor regulator |
| Q35632630 | The ligand binding region of the sigma-1 receptor: studies utilizing photoaffinity probes, sphingosine and N-alkylamines |
| Q33931257 | The oligomeric states of the purified sigma-1 receptor are stabilized by ligands |
| Q92926211 | The sigma-1 receptor behaves as an atypical auxiliary subunit to modulate the functional characteristics of Kv1.2 channels expressed in HEK293 cells |
| Q34356970 | The sigma-1 receptor chaperone as an inter-organelle signaling modulator |
| Q35846559 | The sigma-1 receptors are present in monomeric and oligomeric forms in living cells in the presence and absence of ligands |
| Q35356324 | The sigma1 receptor interacts with N-alkyl amines and endogenous sphingolipids. |
Search more.